Page 9 - எலும்பியல் மருத்துவ பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians and public health leaders a standard tool to measure antibody response to SARS-CoV-2 RARITAN, N.J., May 21, 2021 /CNW/  Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world s largest pure-play in vitro diagnostics companies, today announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test. Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test. Both tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 and are processed on Ortho s trusted VITROS

United statesIvan salgoChockalingam palaniappanClinical laboratory improvement amendmentsInternational standardWorld health organizationDrug administrationTesting solutionsOrtho clinical diagnosticsOrtho clinicalNucleocapsid antibody testEmergency use notificationEmergency use authorizationElaine colOrtho media relationsஒன்றுபட்டது மாநிலங்களில்